Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7567)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nassri AB, Muenyi V, AlKhasawneh A, Ribeiro BDS, Scolapio JS, Malespin M, de Melo Jr SW. Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report. World J Gastrointest Pharmacol Ther 2019; 10(1): 29-34 [PMID: 30697447 DOI: 10.4292/wjgpt.v10.i1.29] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v10/i1/29.htm |
| Number | Citing Articles |
| 1 |
Alan Su, Rodrigo Pedraza, Hagen Kennecke. Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer. Current Oncology 2023; 30(4): 3672 doi: 10.3390/curroncol30040279
|
| 2 |
David Anson, Joseph Norton, Benjamin Chaucer, Saurabh Bansal. Ipilimumab- and Nivolumab-Induced Colitis Causing Severe Hypokalemia and QTc Prolongation. Case Reports in Oncological Medicine 2019; 2019: 1 doi: 10.1155/2019/7896749
|
| 3 |
Preeya Goyal, Justin T. Moyers, Bassem G. Elgohary, Muhammad B. Hammami. Case Report: Nivolumab-Induced Autoimmune Pancreatitis. Journal of Immunotherapy and Precision Oncology 2021; 4(4): 208 doi: 10.36401/JIPO-21-11
|
| 4 |
Neeta Malviya, Ian W. Tattersall, Jonathan Leventhal, Allireza Alloo. Cutaneous immune-related adverse events to checkpoint inhibitors. Clinics in Dermatology 2020; 38(6): 660 doi: 10.1016/j.clindermatol.2020.06.011
|
| 5 |
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología 2024; 47(4): 401 doi: 10.1016/j.gastrohep.2023.10.009
|
| 6 |
Carolina Lopes, Sandra Morgado, Ana I. Plácido, Fátima Roque, Manuel Morgado. Critical Analysis of Immune Checkpoint Inhibitor Immunotoxicity Management. SN Comprehensive Clinical Medicine 2021; 3(1): 84 doi: 10.1007/s42399-020-00670-w
|
| 7 |
Mar Riveiro-Barciela, Sabela carballal, Álvaro Díaz-González, Miriam Mañosa, Javier Gallgo-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera, María-Carlota Londoño. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.10250/2024
|
| 8 |
Manuel Morgado, Ana Plácido, Sandra Morgado, Fátima Roque. Management of the Adverse Effects of Immune Checkpoint Inhibitors. Vaccines 2020; 8(4): 575 doi: 10.3390/vaccines8040575
|
| 9 |
Eveline Daetwyler, Till Wallrabenstein, David König, Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli. Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for ImmunoTherapy of Cancer 2024; 12(1): e007409 doi: 10.1136/jitc-2023-007409
|